Akira Yamanoi
Akira Yamanoi publishes mostly in Hepatology, Surgery and Molecular Biology, on topics such as Hepatocellular Carcinoma Treatment and Prognosis, Organ Transplantation Techniques and Outcomes and Cholangiocarcinoma and Gallbladder Cancer Studies.
- World rank
- #1,331,320 of 7,710,434 ranked researchers
- Rank in Japan
- #20,127 of 383,136
- Works
- 111
- Citations
- 4.7k
- Citations per work
- 42.5
What does Akira Yamanoi research?
Akira Yamanoi's work is mostly in Medicine (56%), Biochemistry, Genetics and Molecular Biology (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences6256.2%
- Medicine6256.2%
- Everything else3733.4%
- Life Sciences1210.4%
- 1Hepatology18% of their works
- 2Surgery16% of their works
- 3Molecular Biology10% of their works
- 4Oncology8% of their works
- 5Epidemiology7% of their works
- 6Pulmonary and Respiratory Medicine7% of their works
Research topics
- Hepatocellular Carcinoma Treatment and Prognosis
- Organ Transplantation Techniques and Outcomes
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Liver physiology and pathology
- Liver Disease and Transplantation
- Liver Disease Diagnosis and Treatment
- Neuropeptides and Animal Physiology
- Gastric Cancer Management and Outcomes
Which keywords describe Akira Yamanoi's research?
The keywords of their largest research topics: Hepatocellular Carcinoma, Clinical Practice Guidelines, Liver Cancer, Management, Biliary Tract Cancer, Cholangiocarcinoma, Ischemia-Reperfusion Injury and Liver Transplantation.
- Receptors
- Gastric Cancer
- NASH
- Liver Cirrhosis
- Liver Regeneration
- Liver Transplantation
- Cholangiocarcinoma
- Management
- Clinical Practice Guidelines
- Hepatocellular Carcinoma
- Liver Cancer
- Biliary Tract Cancer
- Ischemia-Reperfusion Injury
- Hepatic Stellate Cells
- Hepatic Encephalopathy
- NAFLD
- Chemotherapy
- Neuropeptides
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Hepatocellular Carcinoma412 topics
- Clinical Practice Guidelines402 topics
- Liver Cancer331 topic
- Management331 topic
- Biliary Tract Cancer131 topic
- Cholangiocarcinoma131 topic
- Ischemia-Reperfusion Injury131 topic
- Liver Transplantation131 topic
- Hepatic Stellate Cells121 topic
- Liver Regeneration121 topic
- Hepatic Encephalopathy101 topic
- Liver Cirrhosis101 topic
- NAFLD81 topic
- NASH81 topic
- Chemotherapy71 topic
- Gastric Cancer71 topic
- Neuropeptides71 topic
- Receptors71 topic
Where does Akira Yamanoi work?
Akira Yamanoi's main affiliation in the publication record is Shimane University, Japan.
How many publications and citations does Akira Yamanoi have?
OpenAlex counts 111 works and 4,723 citations for Akira Yamanoi, an h-index of 38, ranking #1,331,320 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Akira Yamanoi. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.